Ernexa Therapeutics

(NASDAQ) BTX

Current PriceN/A

Market CapN/A

Since IPO (2021)-100%

5 Year-100%

1 Year-88%

1 Month+105%

Ernexa Therapeutics Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

-$11.39

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Mar 7, 2025

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Mar 7, 2025

BTX News

A researcher studying a sample in a petri dish

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ernexa Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Sanjeev Luther, MBA

Website

www.ernexatx.com

Headquarters

San Diego, CA 92121, US

BTX Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

88%

Net Income Margin

88%

Return on Equity

Return on Capital

Return on Assets

Earnings Yield

N/A

Dividend Yield

7.98%

Payout Ratio

4.30%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$40.69M

Operating Income

$35.71M

EBITDA

$0.00

Operating Cash Flow

$877.82M

Capital Expenditure

$0.00

Free Cash Flow

$877.82M

Cash & ST Invst.

$449.08K

Total Debt

$0.00

Ernexa Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$0.09

+1.2%

Gross Margin

-6700.00%

N/A

Market Cap

N/A

Market Cap/Employee

$1.16

N/A

Employees

N/A

Net Income

-$5.51

+0.7%

EBITDA

-$3.46

+1.3%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$9.18

+4.8%

Accounts Receivable

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.23

+0.5%

Short Term Debt

$0.16

+0.1%

Return on Assets

-145.97%

+0.9%

Return on Invested Capital

-650.52%

+1.3%

Free Cash Flow

-$2.27

+1.1%

Operating Cash Flow

-$2.26

+1.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

TBPHTheravance Biopharma, Inc.

TBPHTheravance Biopharma, Inc.$16.37+2.83%

PRMEPrime Medicine, Inc.

PRMEPrime Medicine, Inc.$3.47+10.51%

TYRATyra Biosciences, Inc.

TYRATyra Biosciences, Inc.$27.18-5.26%

MRVIMaravai LifeSciences Holdings, Inc.

MRVIMaravai LifeSciences Holdings, Inc.$4.99+3.10%

RZLTRezolute, Inc.

RZLTRezolute, Inc.$4.51-1.53%

LENZLENZ Therapeutics, Inc.

LENZLENZ Therapeutics, Inc.$7.20+2.71%

KURAKura Oncology, Inc.

KURAKura Oncology, Inc.$8.77+1.33%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

STISolidion Technology

STISolidion Technology$22.71+3.51%

BBBlackBerry

BBBlackBerry$10.34+0.02%

TAT&T

TAT&T$22.77-0.03%

FOXXFoxx Development

FOXXFoxx Development$5.25+0.84%

SOFISoFi Technologies

SOFISoFi Technologies$17.15+0.03%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$37.76+0.02%

SNAPSnap

SNAPSnap$6.07+0.06%

Questions About BTX

What is the current price of Ernexa Therapeutics?

Ernexa Therapeutics is trading at N/A per share.

What is the 52-week range for Ernexa Therapeutics?

Over the past 52 weeks, Ernexa Therapeutics has traded between N/A and N/A.

How much debt does Ernexa Therapeutics have?

As of the most recent reporting period, Ernexa Therapeutics reported total debt of $389.00K.

How much cash does Ernexa Therapeutics have on hand?

Ernexa Therapeutics reported $9.18M in cash and cash equivalents in its most recent financial results.

What is Ernexa Therapeutics’s dividend yield?

Ernexa Therapeutics does not currently have a dividend yield.

Ernexa Therapeutics

Ernexa Therapeutics Financials at a Glance

BTX News

Why Brooklyn ImmunoTherapeutics Crushed the Market Today

Why Brooklyn ImmunoTherapeutics Stock Crushed It in April

Up 1,300% in the Past Month, Is This Mysterious Biotech a Buy?

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Ernexa Therapeutics

BTX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Ernexa Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BTX

What is the current price of Ernexa Therapeutics?

What is the 52-week range for Ernexa Therapeutics?

How much debt does Ernexa Therapeutics have?

How much cash does Ernexa Therapeutics have on hand?

What is Ernexa Therapeutics’s dividend yield?

Premium Investing Services